⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABEO News
Abeona Therapeutics Inc. Common Stock
Form 8-K
sec.gov
ABEO
Abeona Therapeutics® Provides Business Update Highlighting Building Momentum in ZEVASKYN® Commercial Launch
globenewswire.com
ABEO
Abeona Therapeutics® Announces Date of Fourth Quarter / Full Year 2025 Financial Results and Participation in Upcoming 2026 Leerink Global Healthcare Conference
globenewswire.com
ABEO
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ABEO
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ABEO
Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer
globenewswire.com
ABEO
NKTX
Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in Texas
globenewswire.com
ABEO
Abeona Therapeutics® Announces First Patient Treatment with ZEVASKYN® Gene Therapy
globenewswire.com
ABEO
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ABEO
Abeona Therapeutics® Reports Third Quarter 2025 Financial Results and Corporate Updates
globenewswire.com
ABEO